INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 136 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,933 | +2584.6% | 320 | +1500.0% | 0.00% | – |
Q2 2023 | $221 | -77.8% | 20 | -73.0% | 0.00% | – |
Q1 2023 | $994 | +302.4% | 74 | +270.0% | 0.00% | – |
Q4 2022 | $247 | – | 20 | 0.0% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 20 | -77.0% | 0.00% | – |
Q2 2022 | $1,000 | -50.0% | 87 | -27.5% | 0.00% | – |
Q1 2022 | $2,000 | – | 120 | +500.0% | 0.00% | – |
Q4 2021 | $0 | – | 20 | 0.0% | 0.00% | – |
Q3 2021 | $0 | – | 20 | 0.0% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 20 | -85.2% | 0.00% | – |
Q1 2021 | $3,000 | – | 135 | +575.0% | 0.00% | – |
Q4 2020 | $0 | -100.0% | 20 | -85.6% | 0.00% | – |
Q3 2020 | $6,000 | -14.3% | 139 | 0.0% | 0.00% | – |
Q2 2020 | $7,000 | +600.0% | 139 | +595.0% | 0.00% | – |
Q1 2020 | $1,000 | -50.0% | 20 | 0.0% | 0.00% | – |
Q4 2019 | $2,000 | +100.0% | 20 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | -93.3% | 20 | -89.2% | 0.00% | – |
Q2 2019 | $15,000 | +275.0% | 186 | +353.7% | 0.00% | – |
Q1 2019 | $4,000 | -77.8% | 41 | -77.5% | 0.00% | – |
Q4 2018 | $18,000 | +260.0% | 182 | +451.5% | 0.00% | – |
Q3 2018 | $5,000 | -50.0% | 33 | -72.5% | 0.00% | – |
Q2 2018 | $10,000 | +100.0% | 120 | +37.9% | 0.00% | – |
Q1 2018 | $5,000 | 0.0% | 87 | 0.0% | 0.00% | – |
Q4 2017 | $5,000 | 0.0% | 87 | 0.0% | 0.00% | – |
Q3 2017 | $5,000 | – | 87 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 234,375 | $23,623,000 | 22.67% |
Boxer Capital, LLC | 600,000 | $60,474,000 | 7.47% |
DLD Asset Management, LP | 834,600 | $84,136,000 | 5.77% |
GREAT POINT PARTNERS LLC | 200,000 | $20,158,000 | 2.55% |
BB BIOTECH AG | 575,719 | $58,027,000 | 1.86% |
Elk Creek Partners, LLC | 207,657 | $20,930,000 | 1.74% |
ALTRINSIC GLOBAL ADVISORS LLC | 277,944 | $28,014,000 | 1.34% |
Sarissa Capital Management LP | 54,000 | $5,442,000 | 1.21% |
QCM Cayman, Ltd. | 2,181 | $220,000 | 0.90% |
Opus Point Partners Management, LLC | 3,534 | $356,000 | 0.78% |